医药药筒市场－全球产业规模、份额、趋势、机会和预测：按材料类型、应用、腔室类型、尺寸、治疗领域、最终用户、地区和竞争格局划分，2021-2031年

全球医药药筒市场预计将从 2025 年的 29 亿美元成长到 2031 年的 45.5 亿美元，复合年增长率为 7.81%。

这些由硼硅酸玻璃或聚合物製成的专用圆筒是注射笔和自动注射器等给药装置的关键部件，可确保精准给药。市场成长的主要驱动力是需要长期治疗的慢性病患者人数的增加，以及患者越来越倾向于以患者为中心的自我给药方式。此外，蓬勃发展的生物製药产业也推动了这一需求，该产业需要高稳定性包装来维持药物在储存和使用过程中的安全性和完整性。

国际糖尿病联盟 (IDF) 的报告显示，到 2024 年，全球将有约 5.89 亿成年人患有糖尿病，这表明市场需求规模巨大，也凸显了可靠的胰岛素输注系统（例如胰岛素笔）的重要性。儘管成长势头强劲，但由于生产过程中涉及大量资本投入和技术复杂性，市场扩张仍面临潜在障碍。严格的无菌性和尺寸精度监管要求需要精密的生产环境，这限制了新参与企业快速扩大产能的能力。

市场驱动因素

全球慢性疾病（包括肥胖症和糖尿病）发生率的快速上升是推动药物注射笔广泛应用的主要因素。随着需要长期注射治疗的患者人数增加，人们越来越依赖聚合物或玻璃储液器的多剂量注射笔进行精准的自我给药。胰Glucagon-Like Peptide-1(GLP-1) 受体促效剂的高需求就清楚地体现了这一趋势，这促使製药公司不得不进行大规模的生产调整以维持供应。例如，诺和诺德公司2023年的年度报告显示，其糖尿病和肥胖症治疗部门的销售额增长了38%，达到2151亿丹麦克朗，显示这些基于注射笔的治疗方法已被广泛采用。

同时，生物製药产业的快速成长正推动市场向高端包装解决方案转型。生物製剂和生物相似药通常具有复杂的分子结构，对容器表面非常敏感，需要使用特殊的硼硅酸玻璃和聚合物来维持其稳定性。这种转变也体现在主要组件製造商的财务表现中。肖特製药公司（Schott Pharma）2024年2月发布的第一季财报显示，其增值解决方案（包括先进的密封系统）的营收成长了53%。为了维持这一成长动能并推动更广泛的注射剂生态系统发展，各大製药公司正在大力投资基础建设。例如，礼来公司（Eli Lilly）在2024年宣布，将在位于印第安纳州黎巴嫩的工厂追加投资53亿美元，以提高注射用原料药的生产能力。

市场挑战

医药包装盒市场的成长受到生产所需巨额资本投入和技术复杂性的显着限制。这些初级包装组件的开发需要符合严格尺寸精度和无菌性监管标准的专用设施。这些严苛的要求迫使製造商在无尘室环境和先进设备方面进行大量前期投资，这不仅为新进入者设置了巨大的准入门槛，也限制了现有企业快速扩大生产规模的能力。因此，该行业正努力使供给能力与注射疗法的激增需求相匹配。

这些生产壁垒的影响在无菌注射剂市场频繁出现的供应链中断中显而易见。 2024年，美国卫生系统药剂师协会报告了创纪录的323种药品短缺，这场危机主要归因于监管延误和生产品管的挑战。这项数据凸显了与生产高品质给药系统相关的严格操作要求和合规负担如何直接阻碍了该行业的市场流动性和稳定成长。

市场趋势

大容量药筒的推出正在改变市场格局，这种药筒专为可穿戴式註射器设计，有助于将复杂的生物製药从静脉注射过渡到皮下注射，实现患者自主给药。由于用于治疗自体免疫疾病和肿瘤的高黏度製剂通常需要超过标准笔式註射器3毫升容量的剂量，製造商正在开发与穿戴式给药设备相容的5毫升至10毫升药筒。这项创新使得慢性病患者能够在家中进行自我管理，并减少对医疗服务提供者的依赖。正如肖特製药2024年年度报告所述，包括这些大容量药筒在内的高价值解决方案的收入份额同比增长22%，达到总销售额的55%，这充分体现了它们在现代给药系统中的重要性。

同时，製药业正广泛采用「即用型」（RTU）无菌药盒包装，这显着简化了製药研发人员的填充和表面处理工程。透过将灭菌、清洗和硅化製程外包给包装供应商，製药企业可以避免建造资本密集的前端生产线，并获得小批量治疗药物生产的营运柔软性。随着主要供应商在灌装线相容性方面将RTU平台标准化，这一趋势正在加速发展。例如，Stevanato集团2025年第三季财报显示，其高价值解决方案（包括EZ-fill RTU产品组合）的营收年增47%，达到1.479亿欧元，凸显了预灭菌封装系统的快速普及。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球医药墨水匣市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依材料类型（玻璃墨盒、塑胶墨盒、橡胶墨盒）
  • 依应用方式（牙科麻醉、笔式註射器、自动注射器、穿戴式註射器）
  • 依腔室类型（双腔室、大容量）
  • 按容量（0.5毫升、1.8毫升、2毫升-2.5毫升、3毫升、5毫升、10毫升或以上）
  • 依治疗领域（眼科、呼吸科、神经科、肿瘤科、免疫科、心臟科、糖尿病科、牙科、其他）
  • 依最终用户（製药公司、生技公司、研究机构等）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美药品墨水匣市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲药品墨水匣市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区医药墨水匣市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲医药墨水匣市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美药品墨水匣市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球医药墨水匣市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Schott AG
• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Stevanato Group
• Nipro Corporation
• Berry Global Group, Inc.
• SGD Pharma
• Baxter International Inc.
• Vetter Pharma International GmbH
• Catalent, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Pharmaceutical Cartridges Market is projected to expand from a valuation of USD 2.90 billion in 2025 to USD 4.55 billion by 2031, reflecting a compound annual growth rate of 7.81%. These specialized cylindrical vessels, manufactured from borosilicate glass or polymers, are critical components in drug delivery mechanisms like pen injectors and autoinjectors, ensuring exact dosage accuracy. The market is primarily propelled by the rising prevalence of chronic diseases requiring long-term treatment and a growing preference for patient-centric self-administration. Furthermore, the burgeoning biologics sector reinforces this demand, as it requires high-stability packaging to preserve drug safety and integrity throughout storage and use.

Highlighting the scale of demand, the International Diabetes Federation reported that approximately 589 million adults were living with diabetes globally in 2024, emphasizing the critical need for dependable insulin delivery systems such as cartridge-based pens. Despite these strong growth indicators, market expansion faces potential hurdles due to the significant capital expenditure and technical intricacies involved in manufacturing. The rigorous regulatory requirements for sterility and dimensional precision demand sophisticated production environments, creating barriers that restrict rapid capacity scaling for new market entrants.

Market Driver

The surging global incidence of chronic conditions, specifically obesity and diabetes, serves as the central catalyst for the uptake of pharmaceutical cartridges. As the number of patients requiring long-term injectable therapies rises, there is an increased dependency on multidose pen injectors that utilize these polymer or glass reservoirs for precise self-administration. This trend is clearly illustrated by the high demand for glucagon-like peptide-1 (GLP-1) receptor agonists, which has required massive manufacturing adjustments to maintain supply. For example, Novo Nordisk's 2023 Annual Report noted that sales in its Diabetes and Obesity care division rose by 38% to DKK 215.1 billion, demonstrating the widespread adoption of these cartridge-based treatments.

Concurrently, the market is evolving due to the rapid growth of the biologics sector, which necessitates premium packaging solutions. Because biologics and biosimilars frequently feature complex molecular structures sensitive to container surfaces, specialized borosilicate glass or polymers are essential for maintaining stability. This shift is reflected in the financials of major component manufacturers; Schott Pharma's February 2024 media release regarding Q1 results indicated that revenue from high-value solutions, including advanced containment systems, rose to 53%. To sustain this growth and the wider injectable ecosystem, major pharmaceutical companies are investing heavily in infrastructure, such as Eli Lilly's 2024 commitment of an additional $5.3 billion to its Lebanon, Indiana facility to enhance active pharmaceutical ingredient production for injectables.

Market Challenge

The expansion of the pharmaceutical cartridge market is substantially constrained by the significant capital expenditure and technical complexity required for manufacturing. Developing these primary packaging components demands specialized facilities capable of meeting stringent regulatory standards for dimensional precision and sterility. These exacting requirements force manufacturers to make large upfront investments in cleanroom environments and advanced machinery, creating significant barriers to entry for new competitors while simultaneously restricting the ability of established players to quickly ramp up production. As a result, the industry struggles to align supply capabilities with the escalating demand for injectable therapies.

The consequences of these manufacturing obstacles are clearly visible in the frequent supply chain disruptions affecting the sterile injectables market. In 2024, the American Society of Health-System Pharmacists reported a record high of 323 active drug shortages, a crisis largely stemming from regulatory delays and manufacturing quality control challenges. This statistic highlights how the rigorous operational demands and compliance burdens involved in producing high-quality delivery systems directly hinder market liquidity and the stability of growth within the sector.

Market Trends

The market is undergoing a transformation with the introduction of large-volume cartridges tailored for wearable injectors, facilitating a transition from intravenous infusions to subcutaneous self-administration for complex biologics. Because high-viscosity formulations for autoimmune diseases and oncology often require doses surpassing the standard 3mL limit of pen injectors, manufacturers are creating 5mL to 10mL cartridges compatible with on-body delivery devices. This innovation reduces reliance on healthcare facilities by enabling home management of chronic conditions. As noted in Schott Pharma's 2024 Annual Report, the revenue share of high-value solutions-including these large-volume cartridges-rose to 55% of total sales following a 22% year-on-year increase, signaling their vital importance in modern delivery.

At the same time, the industry is widely adopting Ready-to-Use (RTU) sterile cartridge formats, which significantly streamline the fill-finish process for pharmaceutical developers. By outsourcing sterilization, washing, and siliconization to the packaging supplier, drug manufacturers can bypass capital-intensive front-end processing lines and gain operational flexibility for small-batch therapies. This trend is accelerating as major suppliers standardize RTU platforms for filling line compatibility. For instance, Stevanato Group's Third Quarter 2025 Financial Results reported a 47% year-over-year surge in revenue from high-value solutions, including the EZ-fill RTU portfolio, reaching €147.9 million and highlighting the rapid adoption of pre-sterilized containment systems.

Key Market Players

• Schott AG
• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Stevanato Group
• Nipro Corporation
• Berry Global Group, Inc.
• SGD Pharma
• Baxter International Inc.
• Vetter Pharma International GmbH
• Catalent, Inc.

Report Scope

In this report, the Global Pharmaceutical Cartridges Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Cartridges Market, By Material Type

• Glass Cartridges
• Plastic Cartridges
• Rubber

Pharmaceutical Cartridges Market, By Application

• Dental Anesthesia
• Pen Injectors
• Autoinjectors
• Wearable Injectors

Pharmaceutical Cartridges Market, By Chamber Type

• Dual Chamber
• Large Volume

Pharmaceutical Cartridges Market, By Size

• 0.5ml
• 1.8ml
• 2ml to 2.5ml
• 3ml
• 5ml
• More than 10ml

Pharmaceutical Cartridges Market, By Therapeutics Area

• Ophthalmology
• Respiratory
• Neurology
• Oncology
• Immunology
• Cardiology
• Diabetes
• Dental
• Others

Pharmaceutical Cartridges Market, By End User

• Pharmaceuticals
• Biotechnology
• Research Organizations
• Others

Pharmaceutical Cartridges Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Cartridges Market.

Available Customizations:

Global Pharmaceutical Cartridges Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Cartridges Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material Type (Glass Cartridges, Plastic Cartridges, Rubber)
  • 5.2.2. By Application (Dental Anesthesia, Pen Injectors, Autoinjectors, Wearable Injectors)
  • 5.2.3. By Chamber Type (Dual Chamber, Large Volume)
  • 5.2.4. By Size (0.5ml, 1.8ml, 2ml to 2.5ml, 3ml, 5ml, More than 10ml)
  • 5.2.5. By Therapeutics Area (Ophthalmology, Respiratory, Neurology, Oncology, Immunology, Cardiology, Diabetes, Dental, Others)
  • 5.2.6. By End User (Pharmaceuticals, Biotechnology, Research Organizations, Others)
  • 5.2.7. By Region
  • 5.2.8. By Company (2025)
• 5.3. Market Map

6. North America Pharmaceutical Cartridges Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material Type
  • 6.2.2. By Application
  • 6.2.3. By Chamber Type
  • 6.2.4. By Size
  • 6.2.5. By Therapeutics Area
  • 6.2.6. By End User
  • 6.2.7. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Cartridges Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Chamber Type
      • 6.3.1.2.4. By Size
      • 6.3.1.2.5. By Therapeutics Area
      • 6.3.1.2.6. By End User
  • 6.3.2. Canada Pharmaceutical Cartridges Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Chamber Type
      • 6.3.2.2.4. By Size
      • 6.3.2.2.5. By Therapeutics Area
      • 6.3.2.2.6. By End User
  • 6.3.3. Mexico Pharmaceutical Cartridges Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Chamber Type
      • 6.3.3.2.4. By Size
      • 6.3.3.2.5. By Therapeutics Area
      • 6.3.3.2.6. By End User

7. Europe Pharmaceutical Cartridges Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material Type
  • 7.2.2. By Application
  • 7.2.3. By Chamber Type
  • 7.2.4. By Size
  • 7.2.5. By Therapeutics Area
  • 7.2.6. By End User
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmaceutical Cartridges Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Chamber Type
      • 7.3.1.2.4. By Size
      • 7.3.1.2.5. By Therapeutics Area
      • 7.3.1.2.6. By End User
  • 7.3.2. France Pharmaceutical Cartridges Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Chamber Type
      • 7.3.2.2.4. By Size
      • 7.3.2.2.5. By Therapeutics Area
      • 7.3.2.2.6. By End User
  • 7.3.3. United Kingdom Pharmaceutical Cartridges Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Chamber Type
      • 7.3.3.2.4. By Size
      • 7.3.3.2.5. By Therapeutics Area
      • 7.3.3.2.6. By End User
  • 7.3.4. Italy Pharmaceutical Cartridges Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Material Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Chamber Type
      • 7.3.4.2.4. By Size
      • 7.3.4.2.5. By Therapeutics Area
      • 7.3.4.2.6. By End User
  • 7.3.5. Spain Pharmaceutical Cartridges Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Material Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Chamber Type
      • 7.3.5.2.4. By Size
      • 7.3.5.2.5. By Therapeutics Area
      • 7.3.5.2.6. By End User

8. Asia Pacific Pharmaceutical Cartridges Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material Type
  • 8.2.2. By Application
  • 8.2.3. By Chamber Type
  • 8.2.4. By Size
  • 8.2.5. By Therapeutics Area
  • 8.2.6. By End User
  • 8.2.7. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Cartridges Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Chamber Type
      • 8.3.1.2.4. By Size
      • 8.3.1.2.5. By Therapeutics Area
      • 8.3.1.2.6. By End User
  • 8.3.2. India Pharmaceutical Cartridges Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Chamber Type
      • 8.3.2.2.4. By Size
      • 8.3.2.2.5. By Therapeutics Area
      • 8.3.2.2.6. By End User
  • 8.3.3. Japan Pharmaceutical Cartridges Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Chamber Type
      • 8.3.3.2.4. By Size
      • 8.3.3.2.5. By Therapeutics Area
      • 8.3.3.2.6. By End User
  • 8.3.4. South Korea Pharmaceutical Cartridges Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Material Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Chamber Type
      • 8.3.4.2.4. By Size
      • 8.3.4.2.5. By Therapeutics Area
      • 8.3.4.2.6. By End User
  • 8.3.5. Australia Pharmaceutical Cartridges Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Material Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Chamber Type
      • 8.3.5.2.4. By Size
      • 8.3.5.2.5. By Therapeutics Area
      • 8.3.5.2.6. By End User

9. Middle East & Africa Pharmaceutical Cartridges Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material Type
  • 9.2.2. By Application
  • 9.2.3. By Chamber Type
  • 9.2.4. By Size
  • 9.2.5. By Therapeutics Area
  • 9.2.6. By End User
  • 9.2.7. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pharmaceutical Cartridges Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Chamber Type
      • 9.3.1.2.4. By Size
      • 9.3.1.2.5. By Therapeutics Area
      • 9.3.1.2.6. By End User
  • 9.3.2. UAE Pharmaceutical Cartridges Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Chamber Type
      • 9.3.2.2.4. By Size
      • 9.3.2.2.5. By Therapeutics Area
      • 9.3.2.2.6. By End User
  • 9.3.3. South Africa Pharmaceutical Cartridges Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Chamber Type
      • 9.3.3.2.4. By Size
      • 9.3.3.2.5. By Therapeutics Area
      • 9.3.3.2.6. By End User

10. South America Pharmaceutical Cartridges Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Material Type
  • 10.2.2. By Application
  • 10.2.3. By Chamber Type
  • 10.2.4. By Size
  • 10.2.5. By Therapeutics Area
  • 10.2.6. By End User
  • 10.2.7. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pharmaceutical Cartridges Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Material Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Chamber Type
      • 10.3.1.2.4. By Size
      • 10.3.1.2.5. By Therapeutics Area
      • 10.3.1.2.6. By End User
  • 10.3.2. Colombia Pharmaceutical Cartridges Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Material Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Chamber Type
      • 10.3.2.2.4. By Size
      • 10.3.2.2.5. By Therapeutics Area
      • 10.3.2.2.6. By End User
  • 10.3.3. Argentina Pharmaceutical Cartridges Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Material Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Chamber Type
      • 10.3.3.2.4. By Size
      • 10.3.3.2.5. By Therapeutics Area
      • 10.3.3.2.6. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pharmaceutical Cartridges Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Schott AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Gerresheimer AG
• 15.3. West Pharmaceutical Services, Inc.
• 15.4. Stevanato Group
• 15.5. Nipro Corporation
• 15.6. Berry Global Group, Inc.
• 15.7. SGD Pharma
• 15.8. Baxter International Inc.
• 15.9. Vetter Pharma International GmbH
• 15.10. Catalent, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer